# Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients

> **NCT05720273** · PHASE4 · UNKNOWN · sponsor: **Xiaoyan Jia** · enrollment: 80 (estimated)

## Conditions studied

- Chronic Kidney Disease-Mineral and Bone Disorder

## Interventions

- **DRUG:** palicalcitol

## Key facts

- **NCT ID:** NCT05720273
- **Lead sponsor:** Xiaoyan Jia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05720273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05720273, "Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05720273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*